Extremely high-risk patients with acute coronary syndrome: How "extreme" should lipid-lowering therapy be if the LDL-C target <40 mg/dl is considered?

被引：5
|
作者：
Rallidis, Loukianos S. [1 ]
Tsamoulis, Donatos [2 ]
Leventis, Ioannis [3 ]
Kalogeras, Petros [4 ]
Delakis, Iosif [5 ]
Samiotis, Elefterios [1 ]
Kalantzis, Charalampos [6 ]
Malkots, Belkis [7 ]
Tasoulas, Dimitrios [8 ]
Bouratzis, Vasileios [4 ]
Eleutheriou, Dimitris [9 ]
Dalos, Styliano [10 ]
Potoupni, Victoria [11 ]
Zervakis, Stelio [12 ]
Xygka, Georgia [13 ]
Miliotou, Argyro [14 ]
Papathanasiou, Konstantinos A. [1 ,15 ]
Vlachopoulos, Charalambos [6 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Univ Gen Hosp ATTIKON, Med Sch, Dept Cardiol 2, Athens, Greece
[2] Thriasio Gen Hosp, Dept Cardiol, Elefsina, Greece
[3] Univ Gen Hosp Larissa, Dept Cardiol, Larisa, Greece
[4] Univ Hosp Ioannina, Dept Cardiol 2, Ioannina, Greece
[5] Gen Hosp Nikea, Dept Cardiol 1, Piraeus, Greece
[6] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Med Sch, Dept Cardiol 1, Athens, Greece
[7] Democritus Univ Thrace, Med Sch, Dept Cardiol, Dragana, Alexandroupolis, Greece
[8] Gen Hosp Nikea, Dept Cardiol 2, Piraeus, Greece
[9] Gen Hosp Athens Evangelismos, Dept Cardiol 2, Athens, Greece
[10] Univ Gen Hosp Thessaloniki, Dept Cardiol 1, AHEPA, Thessaloniki, Greece
[11] Aristotle Univ Thessaloniki, Hippokrat Univ Hosp, Dept Cardiol 3, Thessaloniki, Greece
[12] Heraklion Univ Hosp, Dept Cardiol, Iraklion, Greece
[13] Patras Univ Hosp, Dept Cardiol, Patras, Greece
[14] Univ Athens, Alexandra Hosp, Dept Clin Therapeut, Athens, Greece
[15] Natl & Kapodistrian Univ Athens, Attikon Univ Hosp, Med Sch, Dept Cardiol 2, Athens 12462, Greece
来源：
KARDIOLOGIA POLSKA | 2023年 / 81卷 / 10期
关键词：
D O I：
10.33963/KP.a2023.0147
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1012 / 1014
页数：3
相关论文
共 48 条
  • [21] ONLY EIGHT PERCENT OF VERY HIGH-RISK FAMILIAL HYPERCHOLESTEROLEMIA PATIENTS ACHIEVE LDL-CHOLESTEROL TARGET DESPITE BEING ON MAXIMAL CONVENTIONAL LIPID-LOWERING THERAPY
    Bogsrud, Martin Proven
    Graedal, Asgeir
    Johansen, Dan
    Langslet, Gisle
    Hovland, Anders
    Holven, Kirsten
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1714 - 1714
  • [22] ASSOCIATIONS OF PSYCHOSOCIAL RISK FACTORS AND CLINICAL CHARACTERISTICS OF ACUTE CORONARY SYNDROME IN THE PATIENTS WITH TARGET VALUES OF LDL-C LIVING IN THE NORTH
    Kozhokar, Kristina
    Urvantceva, Irina
    Nikolaev, Konstantin
    ATHEROSCLEROSIS, 2017, 263 : E176 - E176
  • [23] Comparing therapeutic gap in lipid-lowering management between high-risk cardiovascular patients after acute coronary syndrome, stroke and critical limb ischemia
    Yan, B. P. Y.
    Chan, C. K. Y.
    Lai, W. H. S.
    To, O. T. L.
    EUROPEAN HEART JOURNAL, 2019, 40 : 540 - 540
  • [24] ACHIEVEMENT OF LDL-C TARGETS IN CHINESE PATIENTS WITH VERY HIGH RISK ATHEROSCLEROTIC CARDIOVASCULAR DISEASE RECEIVING INTENSIVE LIPID LOWERING THERAPY
    Cheng, Y.
    Dong, S.
    Shen, P.
    Sun, Y.
    Lin, H.
    Zhai, S.
    VALUE IN HEALTH, 2022, 25 (01) : S24 - S24
  • [25] Lipid Lowering Therapy for Acute Coronary Syndrome and Coronary Artery Disease: Highlights of the 2017 Taiwan Lipid Guidelines for High Risk Patients
    Li, Yi-Heng
    Chao, Ting-Hsing
    Liu, Ping -Yen
    Ueng, Kwo-Chang
    Yeh, Hung-I
    ACTA CARDIOLOGICA SINICA, 2018, 34 (05) : 371 - 378
  • [26] Failure of LDL-C goals achievement and underuse of lipid-lowering therapies in patients at high and very high cardiovascular risk: Spanish subset from the European SANTORINI study
    Mostaza, J. M.
    Garcia-Ortiz, L.
    Tembra, M. A. Suarez
    Calle, P. Talavera
    Garcia, J. Chimeno
    Perez, V. Escolar
    Diaz-Diaz, J. L.
    Manzano-Espinosa, L.
    Catapano, A. L.
    Ray, K. K.
    Moya, G. Diaz
    Montoya, J. Pedro-Botet
    REVISTA CLINICA ESPANOLA, 2025, 225 (02): : 78 - 84
  • [27] Impact of an Intensive Lipid-Lowering Therapy Protocol on Achieving Target Low-Density Lipoprotein Cholesterol Levels in Patients With Acute Coronary Syndrome
    Seiyama, Kosuke
    Oka, Akihiro
    Miyoshi, Toru
    Sudo, Yuya
    Takagi, Wataru
    Ugawa, Satoko
    Okada, Tomoaki
    Nosaka, Kazumasa
    Doi, Masayuki
    CIRCULATION REPORTS, 2025, 7 (02) : 131 - 138
  • [28] Intensive Lipid-Lowering Therapy With High-Intensity Statins and Ezetimibe at the Time of Admission in Patients With Acute Coronary Syndrome Admitted for Percutaneous Coronary Intervention
    Mahajan, Kunal
    Batra, Aditya
    Gupta, Ashu
    Gupta, Anshul
    Arora, Saurabh
    Gautam, Shana
    Lakra, Swati
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 80 (12) : B235 - B236
  • [29] Trends and predictors of high-intensity statin therapy and LDL-C goal achievement among Thai patients with acute coronary syndrome
    Wongsalap, Yuttana
    Jedsadayanmata, Arom
    JOURNAL OF CARDIOLOGY, 2020, 75 (03) : 275 - 281
  • [30] Effect of the Early Application of Evolocumab on Blood Lipid Profile and Cardiovascular Prognosis in Patients with Extremely High-Risk Acute Coronary Syndrome
    Hao, Yan
    Yang, Yu-Lin
    Wang, Yong-Chao
    Li, Jian
    INTERNATIONAL HEART JOURNAL, 2022, 63 (04) : 669 - 677
12345